Mycobacterium smegmatis D-alanine racemase mutants are not dependent on D-alanine for growth

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 1, 2002, Pages 47-54

  Chacon, O ^a   Feng, Z ^a   Harris, N B ^a   Caceres N E ^a   Adams, L G ^a   Barletta, R G ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO ALANINE; RACEMASE;

ARTICLE; AUXOTROPHY; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BACTERIUM TRANSFORMATION; CHEMICAL ANALYSIS; CULTURE MEDIUM; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE INACTIVATION; MEMBRANE PERMEABILITY; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PEPTIDE SYNTHESIS; PHENOTYPE; PRIORITY JOURNAL;

ALANINE; ALANINE RACEMASE; ANTIBIOTICS, ANTITUBERCULAR; CYCLOSERINE; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM SMEGMATIS; PHENOTYPE;

EID: 0036136146     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.2.47-54.2002     Document Type: Article

References (51)

1. Genetics of cell wall biosynthesis
2. Genetic analysis of peptidoglycan biosynthesis in mycobacteria: Characterization of a ddlA mutant of Mycobacterium smegmatis
3. Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes
4. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis
5. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS
6. The mycobacterial cell wall: Structure, biosynthesis and sites of drug action
7. Isolation and characterization of the aspartokinase and aspartate semialdehyde dehydrogenase operon from mycobacteria
8. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
9. Effects of cycloserine on Mycobacterium tuberculosis in vitro
10. The envelope layers of mycobacteria with reference to their pathogenicity
11. Resistance to D-cycloserine in the tubercle bacilli: Mutation rate and transport of alanine in parental cells and drug-resistant mutants
12. Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine
13. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project
14. Standard short-course chemotherapy for drug-resistant tuberculosis: Treatment outcomes in 6 countries
15. Phage infection, transfection, and transformation of Mycobacterium avium complex and M. paratuberculosis
16. Biosynthetic alr alanine racemase from Salmonella typhimurium: DNA and protein sequence determination
17. The alanine racemase gene is essential for growth of Lactobacillus plantarum
18. The Mycobacterium avium complex
19. Mycobacterium tuberculosis: A once genetically intractable organism
20. Colorimetric determination of cycloserine, a new antibiotic
21. Alanine racemase (Pseudomonas)
22. Mechanism of D-cycloserine action: Alanine racemase from Escherichia coli W
23. Mycobacteriophage L5 integrase-mediated site-specific integration in vitro
24. Organization and expression of the Escherichia coli K-12 dad operon encoding the smaller subunit of D-amino acid dehydrogenase and the catabolic alanine racemase
25. Structure, function, and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information
26. The enzymatic synthesis of D-alanyl-D-alanine. I. Purification and properties of D-alanyl-D-alanine synthetase
27. D-cycloserine and O-carbamyl-D-serine
28. The enzymatic synthesis of D-alanyl-D-alanine. III. On the inhibition of D-alanyl-D-alanine synthetase by the antibiotic D-cycloserine
29. Nucleotide sequence of the kanamycin resistance transposon Tn903
30. Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence
31. Biosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis
32. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange
33. Characterization of a Mycobacterium smegmatis mutant that is simultaneously resistant to D-cycloserine and vancomycin
34. Chemical structure of the cell wall of Mycobacterium smegmatis. I. Isolation and partial characterization of the peptidoglycan
35. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis
36. Biosynthesis of bacterial cell walls
37. Characterization of the alanine racemases from two mycobacteria
38. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis
39. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
40. Pathogenicity and immunogenicity of a Listeria monocitogenes strain that requires D-alanine for growth
41. Permeability of the cell wall of Mycobacterium smegmatis
42. Murein synthesis
43. Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly
44. Catabolic alanine racemase from Salmonella typhimurium: DNA sequence, enzyme purification, and characterization
45. Two alanine racemase genes in Salmonella typhimurium that differ in structure and function
46. The characterization of an alanine racemase mutant of Escherichia coli
47. Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin
48. Antagonism of D-cycloserine inhibition of mycobacterial growth by D-alanine